Kazia Therapeutics is a biotechnology company focused on developing innovative cancer therapies, particularly for difficult-to-treat brain tumors and other malignancies

The company is dedicated to advancing its promising drug candidates through clinical trials, utilizing cutting-edge research and technology to improve patient outcomes. By harnessing the potential of novel compounds, Kazia aims to address significant unmet medical needs in oncology, striving to offer new hope to patients battling various forms of cancer.